Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 788.60B | 795.27B | 851.96B | 733.01B | 551.29B | 508.25B |
Gross Profit | 277.89B | 266.30B | 316.52B | 286.16B | 192.99B | 182.16B |
EBITDA | 190.75B | 190.92B | 240.55B | 230.32B | 157.62B | 134.26B |
Net Income | 131.64B | 133.16B | 170.59B | 155.27B | 94.01B | 73.37B |
Balance Sheet | ||||||
Total Assets | 1.95T | 1.93T | 1.87T | 1.78T | 1.63T | 1.51T |
Cash, Cash Equivalents and Short-Term Investments | 578.70B | 539.08B | 529.23B | 601.22B | 586.78B | 532.56B |
Total Debt | 7.62B | 6.42B | 5.11B | 2.44B | 2.16B | 1.82B |
Total Liabilities | 156.57B | 206.84B | 245.98B | 234.09B | 189.64B | 149.63B |
Stockholders Equity | 1.73T | 1.71T | 1.62T | 1.54T | 1.43T | 1.36T |
Cash Flow | ||||||
Free Cash Flow | 33.80B | 117.88B | 52.44B | 91.22B | 96.23B | 69.44B |
Operating Cash Flow | 48.28B | 171.76B | 99.50B | 125.58B | 118.00B | 144.87B |
Investing Cash Flow | 10.10B | -13.56B | -78.00B | -53.93B | -16.77B | -84.32B |
Financing Cash Flow | -33.41B | -122.51B | -127.92B | -89.15B | -53.13B | -140.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $138.93B | 35.84 | 20.84% | 1.17% | 7.00% | 16.84% | |
77 Outperform | $89.86B | 27.07 | 27.16% | 1.02% | -0.23% | 22.41% | |
77 Outperform | $74.77B | 22.46 | 107.62% | 2.35% | -1.85% | 12.04% | |
76 Outperform | $76.22B | 32.34 | 9.82% | 1.56% | 6.49% | 24.14% | |
69 Neutral | $38.17B | 42.63 | 25.86% | 1.55% | -11.19% | -22.50% | |
64 Neutral | kr63.14B | 12.40 | 1.54% | 10.07% | 0.04% | -3.90% | |
63 Neutral | $25.06B | 26.29 | 8.51% | 1.42% | -5.02% | 6.69% |